Clinical Trial Update: A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an immunomodulatory therapy in adults with perennial allergic rhinitis and house dust mite allergy; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• House Dust Mite Allergy
• Perennial Allergic Rhinitis

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy | Phase 2 | Status: COMPLETED | Results posted: 2013-07-11